To assess cancer-specificity, promoters’ methylation levels of APC, BRCA1, CCND2, FOXA1, PSAT1, RASSF1A and SCGB3A1 were evaluated in Cohort #1 (BrC and NBr tissue samples). This evidence concerns the gene SCGB3A1 and cancer.